Food Safety Educational Training Program to Improve Food Safety Knowledge and Behaviors in Cancer Patients Receiving Treatment

May 12, 2025 updated by: Sanja Ilic, Ohio State University Comprehensive Cancer Center

Efficacy of an Educational Food Safety Intervention for Cancer Patients Receiving Treatment

This clinical trial evaluates the impact of a food safety educational training program on food safety knowledge and behaviors in cancer patients receiving treatment. Cancer treatments, such as chemotherapy, can put patients at risk for foodborne infections and despite this risk, it has been reported that patients do not receive any food safety counseling until they are already experiencing low white blood cell counts. A food safety educational training program may help cancer patients make better choices of low-risk foods and prepare foods safely.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

PRIMARY OBJECTIVE:

I. Evaluate the efficacy of a food safety education intervention for cancer patients.

OUTLINE:

Patients attend a food safety educational training program over 50 minutes on study.

After completion of study intervention, patients are followed up at 5 weeks.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Ohio
      • Columbus, Ohio, United States, 43210
        • Ohio State University Comprehensive Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants must be at least 18 years of age
  • Able to fluently read and converse in English (though it does not have to be their first language)
  • All participants must be diagnosed with cancer, any stage, and be receiving some form of treatment at the aforementioned facilities
  • Informed consent must be obtained from each patient prior to participation in any aspect of the study

Exclusion Criteria:

  • Patients who do not meet these criteria or are not willing or are unable to give informed consent, will be excluded from this study
  • Patients with prescribed dietary limitations or currently on neutropenic diet unrelated to this study will not be included

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Supportive care (food safety educational training)
Patients attend a food safety educational training program over 50 minutes on study.
Other: Questionnaire Administration
Ancillary studies
Other: Educational Intervention
Attend a food safety educational training program
Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in food safety knowledge
Time Frame: From baseline up to 5 weeks post intervention
Pre and post responses will be determined using score calculation and compared using analysis of variance (ANOVA).
From baseline up to 5 weeks post intervention
Changes in attitudes
Time Frame: From baseline up to 5 weeks post intervention
Pre and post responses will be determined using score calculation and compared using ANOVA.
From baseline up to 5 weeks post intervention
Changes in risk perception
Time Frame: From baseline up to 5 weeks post intervention
Pre and post responses will be determined using score calculation and compared using ANOVA.
From baseline up to 5 weeks post intervention
Changes in self-efficacy
Time Frame: From baseline up to 5 weeks post intervention
Pre and post responses will be determined using score calculation and compared using ANOVA.
From baseline up to 5 weeks post intervention
Changes in behaviors
Time Frame: From baseline up to 5 weeks post intervention
Pre and post responses will be determined using score calculation and compared using ANOVA.
From baseline up to 5 weeks post intervention
Changes in food acquisition practices
Time Frame: From baseline up to 5 weeks post intervention
Pre and post responses will be determined using score calculation and compared using ANOVA.
From baseline up to 5 weeks post intervention
Changes in high-risk food consumption
Time Frame: From baseline up to 5 weeks post intervention
Pre and post responses will be determined using score calculation and compared using ANOVA.
From baseline up to 5 weeks post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ohio State University Comprehensive Cancer Center

Investigators

  • Principal Investigator: Sanja Ilic, Ohio State University Comprehensive Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 21, 2022

Primary Completion (Actual)

November 14, 2022

Study Completion (Actual)

November 14, 2022

Study Registration Dates

First Submitted

October 4, 2024

First Submitted That Met QC Criteria

October 4, 2024

First Posted (Actual)

October 8, 2024

Study Record Updates

Last Update Posted (Actual)

May 15, 2025

Last Update Submitted That Met QC Criteria

May 12, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OSU-21049
  • NCI-2024-06192 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malignant Solid Neoplasm

Clinical Trials on Questionnaire Administration

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe